Online Seminar: The Health of Biopharma - Trends in Investments and ExitsMay 09, 2011 Posted by: Ashraf Hebela, CFAJoin our panel of experts on biopharma valuations and venture capital investment in this free Web seminar replay, where they discuss the results of SVB Analytics' latest research findings. Our panel presents and discusses a range of data on operating performance, venture funding and valuations, and exit activity.
See the Web seminar replay [PLAYBACK]
Download the presentation (PDF)
SVB Capital: Private Life Science M&A Analysis (PDF)
Among the topics we will discuss:
A Venture Capital perspective on early and late stage investments in the biopharma sector Recent data on exit multiples, and time-and capital-to-exit SVB Analytics' perspective on biopharma valuations Trends in operating performance Speakers:
Jon Norris, Managing Director, Silicon Valley Bank (moderator)
Garheng Kong, MD, PhD, General Partner, Sofinnova Ventures
Ashraf Hebela, Head of Prod Management, SVB Analytics
Dan Zaelit, Research Associate, SVB Analytics
Read More